Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
+13.47%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$48.4B
AUM Growth
+$13.1B
(+37%)
Cap. Flow
+$9.2B
Cap. Flow
% of AUM
19%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
1,878
New
276
Increased
655
Reduced
560
Closed
216
Top Buys
| 1 |
NVIDIA
NVDA
|
+$651M |
| 2 |
Microsoft
MSFT
|
+$557M |
| 3 |
Salesforce
CRM
|
+$509M |
| 4 |
Apple
AAPL
|
+$405M |
| 5 |
Mastercard
MA
|
+$304M |
Top Sells
| 1 |
Spotify
SPOT
|
+$436M |
| 2 |
Barclays
BCS
|
+$202M |
| 3 |
On Holding
ONON
|
+$186M |
| 4 |
Philip Morris
PM
|
+$142M |
| 5 |
Citigroup
C
|
+$132M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Communication Services | 14.74% |
| 3 | Financials | 13.4% |
| 4 | Healthcare | 10.58% |
| 5 | Consumer Discretionary | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QSG
1151
QuantaSing Group
QSG
$598M
| $472K | ﹤0.01% |
50,277
-42,881
| -46% | -$403K |
|
1152
Broadridge
BR
$29.5B
| $470K | ﹤0.01% |
1,944
-600
| -24% | -$145K |
|
1153
MannKind Corp
MNKD
$1.71B
| $468K | ﹤0.01% |
125,247
-512,053
| -80% | -$1.91M |
|
1154
HUTCHMED
HCM
$3.08B
| $466K | ﹤0.01% |
31,078
+23,355
| +302% | +$350K |
|
1155
Outset Medical
OM
$243M
| $464K | ﹤0.01% |
24,341
-64,958
| -73% | -$1.24M |
|
1156
Fair Isaac
FICO
$37.1B
| $463K | ﹤0.01% |
254
-386
| -60% | -$704K |
|
|
ADAP
1157
Adaptimmune Therapeutics
ADAP
$14.8M
| $459K | ﹤0.01% |
1,964,141
-254,074
| -11% | -$59.4K |
|
1158
Harvard Bioscience
HBIO
$19.7M
| $459K | ﹤0.01% |
1,039,225
-37,844
| -4% | -$16.7K |
|
1159
Johnson Outdoors
JOUT
$422M
| $456K | ﹤0.01% |
15,106
| – | – |
|
1160
HEICO
HEI
$44.4B
| $452K | ﹤0.01% |
1,381
| – | – |
|
1161
Horace Mann Educators
HMN
$1.94B
| $452K | ﹤0.01% |
+10,525
| New | +$452K |
|
1162
Lindsay Corp
LNN
$1.52B
| $449K | ﹤0.01% |
+3,118
| New | +$449K |
|
1163
Skyworks Solutions
SWKS
$11.1B
| $442K | ﹤0.01% |
5,942
| – | – |
|
1164
Genpact
G
$7.41B
| $441K | ﹤0.01% |
10,038
-13,638
| -58% | -$599K |
|
1165
Strawberry Fields REIT
STRW
$154M
| $440K | ﹤0.01% |
42,177
+3,600
| +9% | +$37.6K |
|
1166
Prelude Therapeutics
PRLD
$64M
| $436K | ﹤0.01% |
540,565
+11,238
| +2% | +$9.06K |
|
1167
Safe Bulkers
SB
$466M
| $432K | ﹤0.01% |
120,496
+37,183
| +45% | +$133K |
|
1168
Comscore
SCOR
$34.1M
| $427K | ﹤0.01% |
88,823
| – | – |
|
1169
Zeekr
ZK
$7.45B
| $426K | ﹤0.01% |
+16,707
| New | +$426K |
|
1170
Amicus Therapeutics
FOLD
$2.46B
| $422K | ﹤0.01% |
+73,915
| New | +$422K |
|
1171
Nomura Holdings
NMR
$22B
| $420K | ﹤0.01% |
63,998
+17,352
| +37% | +$114K |
|
1172
TransDigm Group
TDG
$71.6B
| $420K | ﹤0.01% |
277
+4
| +1% | +$6.07K |
|
1173
Parker-Hannifin
PH
$96.1B
| $419K | ﹤0.01% |
601
-198
| -25% | -$138K |
|
1174
Tango Therapeutics
TNGX
$727M
| $419K | ﹤0.01% |
81,953
-891,356
| -92% | -$4.56M |
|
1175
MVB Financial
MVBF
$305M
| $417K | ﹤0.01% |
18,582
-1,171
| -6% | -$26.3K |
|